Takahashi T, Fujiwara Y, Yamakido M, Katoh O, Watanabe H, Mackenzie P I
Second Department of Internal Medicine, Hiroshima University School of Medicine.
Jpn J Cancer Res. 1997 Dec;88(12):1211-7. doi: 10.1111/j.1349-7006.1997.tb00351.x.
Although glucuronidation catalyzed by uridine 5'-diphosphoglucuronosyltransferase (UGT) is a major pathway of drug inactivation in humans, glucuronidation in malignant cells has received little attention as a cause of anti-cancer drug resistance. In this study, we tried to elucidate the role of SN-38 glucuronidation in the CPT-11-resistant human lung cancer cell line PC-7/CPT. PC-7/CPT cells possessed an increased activity to glucuronidate SN-38 compared to the parent cells, PC-7. Furthermore, sensitivity of PC-7/CPT cells to SN-38 was improved by inhibiting UGT activity. Western and northern blot analyses demonstrated that this increased activity was due to increased levels of UGT protein and mRNA. These results not only imply that upregulation of UGT activity in PC-7/CPT cells may contribute in part to SN-38 resistance, but also illustrate the important of drug metabolism within malignant cells themselves, as a cause of drug resistance.
尽管尿苷5'-二磷酸葡萄糖醛酸基转移酶(UGT)催化的葡萄糖醛酸化是人体药物失活的主要途径,但恶性细胞中的葡萄糖醛酸化作为抗癌药物耐药性的一个原因却很少受到关注。在本研究中,我们试图阐明SN-38葡萄糖醛酸化在CPT-11耐药的人肺癌细胞系PC-7/CPT中的作用。与亲本细胞PC-7相比,PC-7/CPT细胞具有更高的SN-38葡萄糖醛酸化活性。此外,抑制UGT活性可提高PC-7/CPT细胞对SN-38的敏感性。蛋白质免疫印迹和Northern印迹分析表明,这种活性增加是由于UGT蛋白和mRNA水平升高所致。这些结果不仅意味着PC-7/CPT细胞中UGT活性的上调可能部分导致了SN-38耐药性,还说明了恶性细胞自身内药物代谢作为耐药性原因的重要性。